Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 13/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11566610 | 0.82 | MEN1 (0.50) | NUDT1MEN1NPC1MAPTPABPC1 | |
| SCHEMBL12639130 | 0.79 | NUDT1 (0.57) | NUDT1NPC1MAPTRAB9A | |
| SCHEMBL30166651 | 0.79 | NUDT1 (0.57) | NUDT1NPC1MAPTRAB9A | |
| SCHEMBL16840718 | 0.79 | NOS3 (0.45) | NUDT1NPC1RAB9AHTR6 | |
| SCHEMBL11037706 | 0.79 | HTR6 (0.47) | NUDT1MAPTRAB9AHTR6 | |
| SCHEMBL3331353 | 0.78 | MAPT (0.50) | NUDT1MEN1NPC1MAPTPABPC1 | |
| SCHEMBL3751497 | 0.77 | NUDT1 (0.55) | NUDT1HTR6 | |
| Hydrochloric Acid SCHEMBL30478057 | 0.77 | NUDT1 (0.55) | NUDT1NPC1MAPTRAB9A | |
| SCHEMBL15757689 | 0.77 | NUDT1 (0.60) | NUDT1HTR6 | |
| SCHEMBL2072360 | 0.77 | NUDT1 (0.55) | NUDT1HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105801494-B | Thin polymer film, retardation films, polarizing film, liquid crystal display and compound | 富士胶片株式会社 | 2019-05-17 | — | — | CN | disclosed |
| US-9656969-B2 | Polymer film, retardation film, polarizing plate, liquid crystal display, and compound | FUJIFILM CORPORATION (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20160159750-A1 | POLYMER FILM, RETARDATION FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2016-06-09 | — | — | US | disclosed |
| US-9296877-B2 | Polymer film, retardation film, polarizing plate, liquid crystal display, and compound | FUJIFILM CORPORATION (JP) | 2016-03-29 | — | — | US | disclosed |
| US-20140363588-A1 | POLYMER FILM, RETARDATION FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2014-12-11 | — | — | US | disclosed |
| US-8871314-B2 | Polymer film, retardation film, polarizing plate, liquid crystal display, and compound | FUJIFILM CORPORATION (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20130266744-A1 | POLYMER FILM, RETARDATION FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2013-10-10 | — | — | US | disclosed |
| CN-103249763-A | Polymer film, phase difference film, polarizing plate, liquid crystal display, and compound | FUJI PHOTO FILM CO LTD | 2013-08-14 | — | — | CN | disclosed |
| US-8008481-B2 | Indazole compounds | ABBVIE INC. | 2011-08-30 | — | — | US | disclosed |
| US-20100280021-A1 | PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS | BERTHEL STEVEN JOSEPH | 2010-11-04 | — | — | US | disclosed |
| US-20090062276-A1 | PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS | BERTHEL STEVEN JOSEPH | 2009-03-05 | — | — | US | disclosed |
| CN-101243081-A | Pyrido[2,3-d]pyrimidine-2,4-diamine compounds as PTP1B inhibitors | HOFFMANN LA ROCHE (CH) | 2008-08-13 | — | — | CN | disclosed |
| CN-101195625-A | Antineoplastic medicament antifolate, its salt and midbody | UNIV SHANGHAI JIAOTONG (CN) | 2008-06-11 | — | — | CN | disclosed |
| EP-1910359-A1 | PYRIDO [2 , 3-D]PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS | F. Hoffmann-Roche AG (CH) | 2008-04-16 | — | — | EP | disclosed |
| US-20070282101-A1 | Indazole compounds | ABBVIE INC. | 2007-12-06 | — | — | US | disclosed |
| WO-2007009911-A1 | PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-01-25 | — | — | WO | disclosed |
| WO-2007009911-A1 | PYRIDO [2 , 3-D] PYRIMIDINE-2 , 4-DIAMINE COMPOUNDS AS PTPlB INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-01-25 | — | — | WO | disclosed |
| US-20070021445-A1 | Pyridopyrimidine protein tyrosine phosphatase inhibitors | BERTHEL STEVEN J | 2007-01-25 | — | — | US | disclosed |
| US-20070021445-A1 | Pyridopyrimidine protein tyrosine phosphatase inhibitors | BERTHEL STEVEN J | 2007-01-25 | — | — | US | disclosed |
| US-20070021445-A1 | Pyridopyrimidine protein tyrosine phosphatase inhibitors | BERTHEL STEVEN J | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070282101-A1 | Indazole compounds | CYP3A43, CYP3A7, UGT1A1 | NUDT1 529/4885MEN1 878/4885NPC1 58/4885 |
| US-20090062276-A1 | PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS | PTPRF, PTPN1, PTPRCAP | NUDT1 1420/4885MEN1 4804/4885NPC1 2525/4885 |
| US-20160159750-A1 | POLYMER FILM, RETARDATION FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY, AND COMPOUND | PYM1, CNKSR1, MYB | NUDT1 3889/4885MEN1 1019/4885NPC1 4563/4885 |
| US-20070021445-A1 | Pyridopyrimidine protein tyrosine phosphatase inhibitors | PTPRF, PTPN1, PTPRCAP | NUDT1 1420/4885MEN1 4804/4885NPC1 2525/4885 |
| US-20100280021-A1 | PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS | PTPRF, PTPN1, PTPRCAP | NUDT1 1420/4885MEN1 4804/4885NPC1 2525/4885 |
| US-20140363588-A1 | POLYMER FILM, RETARDATION FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY, AND COMPOUND | PYM1, CNKSR1, MYB | NUDT1 3951/4885MEN1 1189/4885NPC1 4646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.